Vol 91, No 2 (2020)
Clinical vignette
Published online: 2020-02-12

open access

Page views 1534
Article views/downloads 886
Get Citation

Connect on Social Media

Connect on Social Media

Unusually high plasma values of many tumour markers in a patient with idiopathic pulmonary fibrosis

Leszek Gottwald12, Mateusz Pajdzinski2, Wojciech J. Piotrowski3, Sebastian Majewski3, Piotr Sieroszewski4, Jacek Fijuth12
Pubmed: 32083307
Ginekol Pol 2020;91(2):101.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Martinez FJ, Collard HR, Pardo A, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers. 2017; 3: 17074.
  2. Raghu G, Remy-Jardin M, Myers JL, et al. American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2018; 198(5): 44–68.
  3. Fujita J, Obayashi Y, Yamadori I, et al. Marked elevation of CA19-9 in a patient with idiopathic pulmonary fibrosis: CA19-9 as a bad prognostic factor. Respirology. 1998; 3(3): 211–214.
  4. Maher TM, Oballa E, Simpson JK, et al. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med. 2017; 5(12): 946–955.
  5. Rusanov V, Kramer MR, Raviv Y, et al. The significance of elevated tumor markers among patients with idiopathic pulmonary fibrosis before and after lung transplantation. Chest. 2012; 141(4): 1047–1054.